Epidemiologic Survey to Describe the Current Medical Practice of General Practitioners Treating Subjects With Type 2 Diabetes Mellitus in Latina
NCT01387165 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3592
Last updated 2017-06-08
Summary
The DEAL (Diabetes En America Latina) study was a multicenter, cross-sectional, epidemiological, questionnaire based study carried out between October 2004 and October 2005 in 9 Latin American countries.
Conditions
- Diabetes Mellitus, Type 2
Interventions
- DRUG
-
Treatment
were receiving an oral hypoglycemic agent (OHA) or insulin
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-10-31
- Primary Completion
- 2005-10-31
- Completion
- 2005-10-31
More Related Trials
-
Evaluation of the Efficacy and Safety of Insulin Glargine 300 U/mL in Patients With Type 2 Diabetes Mellitus Uncontrolled on Other Kinds of Insulin
NCT03760991 ·Status: COMPLETED ·Phase: PHASE4
-
A Research Study Looking at Blood Sugar Control in People With Type 2 Diabetes Previously Treated With Premix Insulin and Initiating Treatment With Insulin Degludec/Liraglutide (IDegLira) in Local Clinical Practice in Croatia
NCT05479591 ·Status: WITHDRAWN
-
Complications in Central American Diabetic Patients: Historic Cohort
NCT02486237 ·Status: COMPLETED
-
Insulin Glargine in Type 2 Diabetic Patients
NCT00347100 ·Status: COMPLETED ·Phase: PHASE4
-
Type 2 Diabetes Management With Lantus® (Malbec: Manejo Con Lantus® de Diabéticos Tipo 2)
NCT00627471 ·Status: TERMINATED ·Phase: PHASE4
-
Long-Term Effects of Insulin Plus Metformin Regimens on the Overall and Postprandial Glycemic Control of Patients With Type 2 Diabetes
NCT00191464 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Study of Glycaemic Control in Patients Uncontrolled on Oral Antidiabetic Agents and Starting With 1 (Once) Daily Levemir® (Insulin Detemir) as the Treatment of Type 2 Diabetes Mellitus
NCT00687284 ·Status: COMPLETED
-
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period
NCT02787551 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Patients With Type 2 Diabetes Mellitus
NCT01435616 ·Status: COMPLETED ·Phase: PHASE3
-
A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes
NCT00330473 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control
NCT00701831 ·Status: COMPLETED ·Phase: PHASE4
-
A Study for Patients With Type 2 Diabetes
NCT01027871 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison Between Glargine and Detemir Insulin in Type 2 Diabetes
NCT00457093 ·Status: COMPLETED ·Phase: NA
-
Study on How Fiasp® Can Influence Blood Sugar Levels of type1 Diabetic Patients in Their Daily Lives, With the Help of the Freestyle Libre® Device
NCT03450863 ·Status: COMPLETED
-
Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study
NCT01121835 ·Status: COMPLETED ·Phase: PHASE4
-
RISE Pediatric Medication Study
NCT01779375 ·Status: COMPLETED ·Phase: PHASE3
-
iGlarLixi CGM Study in Chinese T2D Individuals After OADs
NCT06671587 ·Status: RECRUITING ·Phase: PHASE4
-
Observational Study to Observe the Efficacy of Levemir® (Insulin Detemir) in Patients With Type 2 Diabetes.
NCT00793273 ·Status: COMPLETED
-
Insulin Schemes for Type 2 Diabetes Control
NCT03350984 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Optimize Insulin Treatment by Basal Regimen With Insulin Glargine in Type-2-Diabetic Patients Previously Uncontrolled on Premixed Insulin
NCT00693771 ·Status: COMPLETED ·Phase: PHASE4
-
24 Hour Plasma Glucose Profiles Comparing Lispro Mix 75/25 vs. Glargine
NCT00551538 ·Status: COMPLETED ·Phase: PHASE4
-
Insulin Glulisine in Type 2 Diabetes Mellitus
NCT00310297 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study in Type 2 Diabetics Treated by an Intensive Insulin Treatment of Levemir®
NCT00806897 ·Status: COMPLETED
-
The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction
NCT01542476 ·Status: COMPLETED
-
Insulin Glargine in Type 2 Diabetes Mellitus
NCT00272077 ·Status: COMPLETED ·Phase: PHASE4